High rates of neurodevelopmental disability are the one downside of improved survival among kids with congenital heart disease. Here’s why Cleveland Clinic created a Neurocardiac Clinic for these patients’ unique needs.
NIH-sponsored project aims to establish normal ECG reference values as a step toward preventing sudden death in the young. Cleveland Clinic Children’s Pediatric Cardiology Chair leads the charge.
Here’s the lowdown on why echo is the go-to imaging test, when and why other modalities may be needed, and why specialized pediatric imaging expertise matters for young hearts.
Dr. Saarel is a pediatric electrophysiologist who returns to Cleveland Clinic after a decade at the University of Utah. She fields questions about her research passions, essential trends in pediatric cardiology and more.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Uncovering the nature, extent and significance of systemic vascular involvement in pulmonary arterial hypertension (PAH) may unlock a correlation to disease severity or response to therapy, leading to future treatment options
A faculty of over 50 pediatric experts explores practice implications of the year’s most important advances in pediatric care June 11-13 at Cleveland Clinic Children’s Pediatric Innovation Summit.
Covered stents could make transcatheter techniques safer for patients with congenital cardiac lesions. Cleveland Clinic pediatric cardiologists see promising results in clinical trials.
ToF is the most common complex lesion seen in adults with congenital heart disease. The condition is usually—but not always—diagnosed around birth and requires follow-up for long-term complications.
The increasing role percutaneous interventions play in congenital heart disease presents new challenges, including the need to limit radiation exposure and the need to tailor devices to small bodies.